Viberzi is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Eluxadoline.
| Product ID | 61874-075_0ad2e4fc-955d-41f7-a2ae-45e92b6bcefd | 
| NDC | 61874-075 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Viberzi | 
| Generic Name | Eluxadoline | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-10-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206940 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | ELUXADOLINE | 
| Active Ingredient Strength | 75 mg/1 | 
| Pharm Classes | Opioid mu-Receptor Agonists [MoA], mu-Opioid Receptor Agonist [EPC] | 
| DEA Schedule | CIV | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2015-10-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206940 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-10-01 | 
| Marketing Category | NDA | 
| Application Number | NDA206940 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2015-10-01 | 
| Ingredient | Strength | 
|---|---|
| ELUXADOLINE | 75 mg/1 | 
| SPL SET ID: | 7821bd40-4c84-4984-951b-6436ae20421a | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 61874-075 | Viberzi | Eluxadoline | 
| 61874-100 | Viberzi | Eluxadoline | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  VIBERZI  86803941  4982924 Live/Registered | ALLERGAN HOLDINGS UNLIMITED COMPANY 2015-10-29 | 
|  VIBERZI  86481014  4928665 Live/Registered | ALLERGAN HOLDINGS UNLIMITED COMPANY 2014-12-15 |